ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Virocell Biologics Ltd

Virocell Biologics Ltd is a in administration company incorporated on 20 November 2020 with the registered office located in London, City of London. Virocell Biologics Ltd was registered 5 years ago.
Status
In Administration
In administration since 4 days ago
Company No
13033264
Private limited company
Age
5 years
Incorporated 20 November 2020
Size
Unreported
Confirmation
Due Soon
Dated 3 December 2024 (1 year ago)
Next confirmation dated 3 December 2025
Due by 17 December 2025 (8 days remaining)
Last change occurred 11 months ago
Accounts
Due Soon
For period 1 Jan31 Dec 2023 (12 months)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2024
Due by 31 December 2025 (22 days remaining)
Address
Frp Advisory Trading Ltd
110 Cannon Street
London
EC4N 6EU
Address changed on 4 Dec 2025 (4 days ago)
Previous address was Frp Advisory Trading Ltd 110 Cannon Street London EC4N 6EU
Telephone
Unreported
Email
Unreported
People
Officers
7
Shareholders
63
Controllers (PSC)
1
Director • Non-Executive Director • American • Lives in United States • Born in Oct 1955
Director • British • Lives in UK • Born in Aug 1953
Director • Non-Executive Director • British • Lives in UK • Born in Sep 1959
Director • Pharmaceutical Executive • American • Lives in United States • Born in Dec 1960
Director • Non Executive Director • American • Lives in United States • Born in Aug 1963
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
No mutual companies found
Brands
ViroCell Biologics
ViroCell Biologics is a CDMO that specializes in the design and GMP manufacture of lentiviral and gamma-retro viral vectors for cell and gene therapies.
Financials
Net Assets, Total Assets & Total Liabilities (2021–2023)
Period Ended
31 Dec 2023
For period 31 Dec31 Dec 2023
Traded for 12 months
Cash in Bank
£6.05M
Decreased by £4.05M (-40%)
Turnover
Unreported
Same as previous period
Employees
57
Increased by 20 (+54%)
Total Assets
£7.78M
Decreased by £2.97M (-28%)
Total Liabilities
-£4.35M
Increased by £2.68M (+161%)
Net Assets
£3.42M
Decreased by £5.65M (-62%)
Debt Ratio (%)
56%
Increased by 40.43% (+260%)
Latest Activity
Registered Address Changed
4 Days Ago on 4 Dec 2025
Registered Address Changed
4 Days Ago on 4 Dec 2025
Administrator Appointed
4 Days Ago on 4 Dec 2025
New Charge Registered
2 Months Ago on 29 Sep 2025
John Andrew Dawson Details Changed
6 Months Ago on 29 May 2025
Dr Farzin Farzaneh Details Changed
6 Months Ago on 29 May 2025
John David Enloe Details Changed
6 Months Ago on 29 May 2025
Susan Dexter Details Changed
6 Months Ago on 29 May 2025
Cedriane Marie De Boucaud Truell Details Changed
6 Months Ago on 29 May 2025
Todd C Davis Details Changed
6 Months Ago on 29 May 2025
Get Credit Report
Discover Virocell Biologics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Appointment of an administrator
Submitted on 4 Dec 2025
Registered office address changed from Frp Advisory Trading Ltd 110 Cannon Street London EC4N 6EU to Frp Advisory Trading Ltd 110 Cannon Street London EC4N 6EU on 4 December 2025
Submitted on 4 Dec 2025
Registered office address changed from The Portland Building 27-28 Church Street Brighton East Sussex BN1 1RB United Kingdom to Frp Advisory Trading Ltd 110 Cannon Street London EC4N 6EU on 4 December 2025
Submitted on 4 Dec 2025
Registration of charge 130332640001, created on 29 September 2025
Submitted on 30 Sep 2025
Memorandum and Articles of Association
Submitted on 21 Aug 2025
Resolutions
Submitted on 21 Aug 2025
Resolutions
Submitted on 28 Jul 2025
Memorandum and Articles of Association
Submitted on 28 Jul 2025
Director's details changed for John Andrew Dawson on 29 May 2025
Submitted on 30 May 2025
Director's details changed for Susan Dexter on 29 May 2025
Submitted on 29 May 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year